Dr. Wafaa El-Sadr, ICAP director, is protocol chair for the HPTN 065 or Test Link to Care Plus Treat (TLC-Plus) Study. HPTN 065 is being conducted in the Bronx and in Washington, DC and involves 37 HIV testing sites and 39 HIV care sites in the two communities. HPTN 065 aims to determine the feasibility of enhanced testing, linkage and treatment as a strategy for HIV prevention in the U.S.
Community input played an important role in the design of the study, explained Dr. El-Sadr, who is also professor of Epidemiology and Medicine at Columbia's Mailman School. "Before we introduced our financial incentive, we had to think so carefully about what can happen that's good and what can undermine what you're trying to do," she said. "And we want to use incentives that, if they are effective, will be cost-effective for health systems."
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.Visit our hiv / aids section for the latest news on this subject. Findings of the study are featured in Science magazine's July 13 special issue, "HIV/AIDS in America," published on the eve of the International AIDS Conference (AIDS 2012) in Washington, D.C.
The paper: Pay Now, Benefits Later.
The study is funded by National Institute of Allergy and Infectious Diseases (NIAID), the National Institute of Mental Health (NIMH) and the Centers for Disease Control and Prevention (CDC). The study is conducted in collaboration with CDC and health departments in the following cities: New York City, Washington, DC, Chicago, Houston, Miami and Philadelphia.
Columbia University's Mailman School of Public Health Please use one of the following formats to cite this article in your essay, paper or report:
No comments:
Post a Comment
Note: only a member of this blog may post a comment.